EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Therapeutic delivery of microRNAs discovered to target deregulated glioblastoma pathways inhibits tumor growth in mice

Shekhar Saha, Ying Zhang, Myron K Gibert, Collin Dube, Farina Hanif, Elizabeth Qian Xu Mulcahy, Sylwia Bednarek, Yunan Sun, Pawel Marcinkiewicz, Xiantao Wang, Gijung Kwak, Ahsan Polash und 21 weitere

Journal of Clinical Investigation · 17.08.2026 · 136 (16)

DOI: 10.1172/jci195639 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Clinical Investigation, online erschienen am 30.06.2026. Verfasst von Shekhar Saha und 32 weiteren Autor:innen. Beteiligte Einrichtung: Department of Microbiology, Immunology, and Cancer Biology, University of Virginia School of Medicine, Charlottesville, Virginia, USA. Hauptthemen laut MEDLINE: MicroRNAs, Glioblastoma, Brain Neoplasms, RNA, Neoplasm. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 53 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NCI NIH HHS, NINDS NIH HHS, National Cancer Institute.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Glioblastoma is a fatal primary malignant brain tumor, with an average survival of 15 months despite surgical resection, chemotherapy, and radiation therapy. Due to the concurrent deregulation of numerous genes in glioblastoma, molecular monotherapies have not improved clinical outcomes. Evidence suggests that targeting multiple deregulated molecules is essential for better therapies; however, this is limited by the lack of suitable drugs and increased toxicity of combination therapies. To address this, we hypothesized that miRNAs, small gene-regulatory RNAs that suppress mRNA, could simultaneously inhibit multiple deregulated genes in glioblastoma and be used for more effective therapies. We identified regulatory miRNAs — those that target several deregulated genes in glioblastoma — using a combination of PAR-CLIP screening, TCGA data analyses, and an algorithm to rank target importance and miRNA therapeutic potential. We selected 2 tumor-suppressive miRNAs, miR-340 and miR-382, and 1 oncogenic miRNA, miR-17, and showed that they targeted critical glioblastoma pathways and altered cell growth, survival, invasion, and in vivo tumor growth. We developed and successfully applied a miRNA therapeutic delivery approach using brain-penetrating nanoparticles combined with MRI-guided focused ultrasound and microbubbles, to inhibit established tumor growth and extend animal survival. This strategy offers a promising approach for translating miRNA-based therapies into clinical trials for glioblastoma and other cancers. We developed and used new computational, experimental, and therapeutic approaches to identify and therapeutically deliver master regulatory miRNAs to inhibit the growth of glioblastoma, the most common and deadly primary brain tumor.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

MicroRNAsGlioblastomaBrain NeoplasmsRNA, NeoplasmAnimalsHumansMiceCell Line, TumorGene Expression Regulation, NeoplasticXenograft Model Antitumor Assays

Stichwörter der Autor:innen

Brain cancerCell biologyNoncoding RNAsOncology

Substanzen

MicroRNAsRNA, Neoplasm

Autor:innen und Institutionen

  • Department of Microbiology, Immunology, and Cancer Biology, University of Virginia School of Medicine, Charlottesville, Virginia, USA.
  • Department of Biochemistry, Dow International Medical College, Dow University of Health Sciences, OJHA Campus, Karachi, Pakistan.
  • National Institute of Arthritis and Musculoskeletal and Skin Diseases, NIH, Bethesda, Maryland, USA.
  • Department of Neurosurgery and.
  • Medicine Institute for Neuroscience Discovery (UM-MIND), School of Medicine, University of Maryland, Baltimore, Maryland, USA.
  • Department of Chemical and Biomolecular Engineering, School of Engineering, Johns Hopkins University, Baltimore, Maryland, USA.

Förderung

  • NCI NIH HHS
  • NINDS NIH HHS
  • National Cancer Institute
  • National Institute of Neurological Disorders and Stroke

Zitieren

APA

Saha, S., Zhang, Y., Gibert, M. K., Dube, C., Hanif, F., Mulcahy, E. Q. X., Bednarek, S., Sun, Y., Marcinkiewicz, P., Wang, X., Kwak, G., Polash, A., Li, H., Hudson, K., Dinda, M., Saha, T., McCord, M., Guessous, F., Cruickshanks, N., …, & Abounader, R. (2026). Therapeutic delivery of microRNAs discovered to target deregulated glioblastoma pathways inhibits tumor growth in mice. Journal of Clinical Investigation, 136(16). https://doi.org/10.1172/jci195639

Vancouver

Saha S, Zhang Y, Gibert MK, Dube C, Hanif F, Mulcahy EQX, et al. Therapeutic delivery of microRNAs discovered to target deregulated glioblastoma pathways inhibits tumor growth in mice. Journal of Clinical Investigation. 2026;136(16). doi:10.1172/jci195639

BibTeX
@article{Saha2026,
  author = {Saha, Shekhar and Zhang, Ying and Gibert, Myron K and Dube, Collin and Hanif, Farina and Mulcahy, Elizabeth Qian Xu and Bednarek, Sylwia and Sun, Yunan and Marcinkiewicz, Pawel and Wang, Xiantao and Kwak, Gijung and Polash, Ahsan and Li, Haolin and Hudson, Kadie and Dinda, Manikarna and Saha, Tapas and McCord, Matthew and Guessous, Fadila and Cruickshanks, Nichola and Rivera Colon, Rossymar and Dell'Olio, Lily and Anbu, Rajitha and Liu, Wenjie and Choi, Songy and Kefas, Benjamin and Kumar, Pankaj and Klibanov, Alexander L and Schiff, David and Suk, Jung Soo and Hanes, Justin and Mata, Jamie and Hafner, Markus and Abounader, Roger},
  title = {Therapeutic delivery of microRNAs discovered to target deregulated glioblastoma pathways inhibits tumor growth in mice},
  journal = {Journal of Clinical Investigation},
  year = {2026},
  volume = {136},
  number = {16},
  doi = {10.1172/jci195639}
}
Kostenlos starten →